Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme.

ABSTRACT:

Objectives

This study aims to estimate the prevalence of coronavirus disease 2019 (COVID-19) in the general population of Iran.

Methods

The target population was all Iranian people aged 6 years and older in the country. A stratified random sampling design was used to select 28 314 people from among the individuals registered in the electronic health record systems used in primary health care in Iran. Venous blood was taken from each participant and tested for the IgG antibody against COVID-19. The prevalence of COVID-19 was estimated at provincial and national levels after adjusting for the measurement error of the laboratory test, non-response bias and sampling design.

Results

Of the 28 314 Iranians selected, 11 256 (39.75%) participated in the study. Of these, 5406

SUBMITTER: Khalagi K 

PROVIDER: S-EPMC8226066 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature